Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear factor erythroid-derived 2-related factor 2 (Nrf2) is a transcription factor that plays a central role in cellular defense mechanisms against oxidative and electrophilic stress. It regulates the expression of numerous cytoprotective genes involved in antioxidant defense, detoxification, metabolism, inflammation, proteostasis, mitochondrial function and immune responses. Nrf2 is regulated by Keap1, which sequesters it in the cytoplasm and promotes its degradation under normal conditions. Upon exposure to stress, Nrf2 translocates to the nucleus, dimerizes with small Maf proteins, and activates the transcription of target genes containing antioxidant response elements (AREs).
Pharmacological activation by disrupting Keap1-Nrf2 binding, leading to Nrf2 nuclear translocation and ARE-mediated gene transcription.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear factor erythroid-derived 2-related factor 2 (Nrf2).